Serum screening for down’s syndrome between 8 and 14 weeks of pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 5, 1996, Pages 407-412

  Wald, N J ^a   George, L ^a   Smith, D ^a   Densem, J W ^a   Pettersonm, K ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Wallac Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTICENTER STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING; SERODIAGNOSIS;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; INHIBINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0029886420     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09765.x     Document Type: Article

References (28)

1. Wald NJ, Kennard A, Smith D. First trimester biochemical screening for Down's syndrome. Ann Med 1994; 26: 23–29.
2. Preissner CM, Klee GG, Scheithauer BW, Abboud CF. Free a subunit of the pituitary glycoprotein hormones: measurement in serum and tissue of patients with pituitary tumors. Am J Clin Pathol 1990; 94: 417–421.
3. Pettersson K, Norgaard-Pedersen B, Stenman U, Stigbrand T. Optimization of immunometric assays for the measurement of PAPP-A first trimester samples from normal and trisomy 21 pregnancies. In: Screening for Down's Syndrome; Royal College of Obstetricians and Gynaecologists; 1993 May 24–26. Abstract No. 35.
4. Groome P, Illingworth PJ, OBrian M, Cooke I, Ganesan TS, McNeilly AS. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994; 40: 717–723.
5. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Human Reprod 1994; 9: 1634–1642.
6. Wald NJ, Cuckle HS, Densem JW et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883–887.
7. Office of Population Censuses and Surveys (1985–90). Birth Stat. Series FMl, Nos. 11, 12, 15–17. London : HMSO, 1991.
8. Cuckle H, Lilford RJ, Teisner B, Holdings, Chard, T, Grudzinskas JG. Pregnancy associated plasma protein A in Down's syndrome. BMJ 1992; 305: 425.
9. Wald N, Densem J, Stone R, Cheng R. The use of free β-hCG in antenatal screening for Down's syndrome. Br J Obstet Gynaecol 1993; 100: 550–557.
10. Wald NJ, Densem JW, Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994; 14:707–716.
11. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387–402.
12. Muller F, Cuckle H, Teisner B, Grudzinskas JG. Serum Papp-A levels are depressed in women with fetal Down's syndrome in early pregnancy. Prenat Diagn 1993; 13: 633–636.
13. Ozturk M, Milunsky A, Brambati B, Sachs ES, Miller SL, Wands JR. Abnormal maternal levels of human chorionic gonadotropin free subunits in Trisomy 18. Am J Med Genet 1990; 36: 480–483.
14. Kratzer PG, Golbus MS, Sorg ND, Jones OW. Human chorionic gonadotrophin (hCG), free αhCG and progesterone. Prenat Diagn 1991; 11: 751–765.
15. Iles RK, Sharma K, Wathen NC et al. HCG, free subunit and PAPP-A composition of maternal serum in normal and Down's syndrome pregnancies. In: Fourth conference: Endocrinology and Metabolism in Human Reproduction; 1993 May; London.
16. Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin as a first trimester marker of Down's syndrome. Prenat Diagn 1995; 15: 359–362.
17. Van Lith JMM, Mantingh A, Pratt JJ. First trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Obstet Gynecol 1994; 83: 661–664.
18. Wallace EM, Harkness LM, Bums S, Liston WA. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clin Epidemiol 1994; 41: 483–486.
19. Snijders RJM, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risks for trisomies at 9–14 weeks' gestation. Prenat Diagn 1994; 14: 543–552.
20. Macintosh MCM, Wald NJ, Chard T et al. The selective miscarriage of Down's syndrome from 10 weeks of pregnancy. Br J Obstet Gynaecol 1995; 102: 798–801.
21. Smidt-Jensen S, Prmin M, Philip J. Sampling success and risk by transabdominal chorionic villus sampling, transcervical chorionic villus sampling and amniocentesis: a randomized study. Ultrasound Obstet Gynecoi 1991; 1: 86.
22. Nicolaides K, Brizot, M de L, Patel F, Snijders R. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10–13 weeks' gestation. Lancet 1994; 344: 435–439.
23. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. Lancet 1989; 1: 1–6.
24. MRC UK. MRC European trial of chorion villus sampling. Lancet 1991; 337: 1491–1499.
25. Szabo J, Gellen J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 1990; 336: 1133.
26. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. BMJ 1992; 304: 867–869.
27. Firth HV, Boyd PA, Chamberlain PF, MacKenzie IZ, Morriss-Kay GM, Huson SM. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994; 343: 1069–1071.
28. Olney RTS, Khoury MJ, Botto LD, Mastroiacovo P. Limb defects and gestational age at chorionic villus sampling. Lancet 1994; 344: 476.